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In vivo imaging is a novel experimental approach for biological research. Multiphoton microscopy (MPM),
a type of ﬂuorescence microscopy, is a new tool for in vivo imaging analysis. MPM allows observation of
both tissue structures and cell behaviors or cellecell interactions in living animals in real time. Skin is an
ideal tissue for MPM analysis as it is directly accessible to the microscope. In the skin, immune cells
cooperate to maintain skin homeostasis or to exert immune responses against foreign antigens. In vivo
imaging by MPM analysis provides precise information on cell dynamics in the skin, and has signiﬁcantly
expanded our knowledge of the cutaneous immune system. In this review, wewill discuss recent insights
related to the mechanisms of allergic skin inﬂammation that have been revealed by MPM analysis.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The skin contains various kinds of immune cells, such as den-
dritic cells (DCs), T cells, and mast cells (MCs). Their dynamic in-
teractions are essential for the maintenance of homeostasis and
also for the induction/regulation of cutaneous immune re-
sponses.1,2 For example, DCs continuously migrate and scan anti-
gens in the skin. When DCs capture antigens, they present them to
effector T cells, which then activate and produce various cytokines
to eliminate the antigens. Here, to exert their effector functions togy, Kyoto University Graduate
606-8501, Japan.
Honda), kaba@kuhp.kyoto-u.
ety of Allergology.
rgology. Production and hosting by Elsean appropriate extent and with correct timing, their motility and
the duration of interaction must be tightly regulated spatiotem-
porally. If not, these immune responses may cause unnecessary
tissue damages as a result of excessive T cell activations, or they
may instead fail to protect the host from the antigens due to
inadequate T cell activations.
Until recently, cell dynamics analysis has mainly been per-
formed by in vitro systems. For example, chemotaxis chamber assay
is frequently performed to investigate cell migration ability in vitro.
However, it remains unknown whether such cell dynamics in a
culture system actually reﬂect in vivo cell behaviors, since tissue
conditions, such as collagen ﬁber structures, blood supply, oxygen
concentration and cellecell interactions, signiﬁcantly affect cell
dynamics in vivo. Immunohistochemical analysis is the conven-
tional method used to analyze cell localization and behaviors in
tissues. Although this analysis can extract in vivo information, it
provides a static picture of a certain speciﬁc moment in thevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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information related to cell dynamics. For the accurate evaluation of
cell movement and cellecell interaction in vivo, direct observation
of the cells in a living animal is necessary.
Multiphoton microscopy (MPM) is a type of ﬂuorescence mi-
croscopy that excites ﬂuorophores with long-wavelength photons.
Since the excitation of ﬂuorophores with multiphotons occurs only
on focal planes, the resolution of MPM is very high. In addition,
long-wavelength photons penetrates deep into tissues with low
phototoxicity, which enables long time-lapse observation with
minimal tissue damages. Moreover, some tissue structures, such as
collagen ﬁbers and elastins, are visualized without ﬂuorescent la-
beling by multiphoton excitation. Based on these characteristics,
MPM is a useful tool for in vivo imaging with subcellular resolu-
tions. Using this technique, we have investigated immune cell dy-
namics in various skin conditions.3e7 In this review, we will
introduce how MPM analysis has expanded our knowledge of the
cutaneous immune systems in allergic inﬂammation, with a focus
on contact dermatitis.Contact dermatitis
Contact dermatitis, such as metal allergy and plant allergy, is a
kind of delayed-type hypersensitivity in skin, and is a common
allergic skin disease affecting approximately 15e20% of the world's
populations.8 Contact hypersensitivity (CHS) is a frequently used
mouse model of contact dermatitis. Chemicals that induce contact
dermatitis and CHS are small compounds called haptens.9,10 Hap-
tens binds to self-proteins, which become immunogenic neo-an-
tigens.10 Haptens or haptenized self-proteins activate innate
immune cells, such as keratinocytes, MCs, and macrophages, whichSensiƟzaƟon 
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play inhibitory roles in both the sensitization and elicitation phases.produce various chemical mediators, and induce two important
phases in CHS: the sensitization phase and the elicitation phase
(Fig. 1). In the sensitization phase, skin DCs capture antigens
(hapten-self complex), andmigrate to draining lymph nodes (dLNs)
to induce differentiation and proliferation of antigen speciﬁc T cells
(mainly Th1 and Tc1 cells). When the same hapten enters the skin,
the antigen-speciﬁc T cells are activated in the skin by antigen-
captured cutaneous DCs. The activated T cells produce various cy-
tokines/chemokines and induce skin inﬂammation.11 This inﬂam-
matory phase is called the elicitation phase. Using the CHS model,
we have analyzed how DC and T cell dynamics are regulated in the
skin during allergic inﬂammation.12e14DC dynamics after hapten application
At least three DC subsets have been identiﬁed in the skin:
Langerhans cells (LCs; located in the epidermal layer) and two
dermal DC (dDC) populations. These two dDC subsets express
different patterns of surface molecules and are classiﬁed as
langerin-positive (or CD103-positive) DCs and langerin-negative
(or CD11b-positive) dDCs.2 In the sensitization phase, dDCs, espe-
cially langerin-positive dDCs, are considered to be the essential cell
populations thatmediate the sensitization,15e17 although other dDC
subsets have the ability to exert the functions.18e22
CD11c-YFP mice, which express yellow ﬂuorescence protein
(YFP) under the transcriptional control of mouse integrin alpha X
(CD11c), are frequently used for the visualization of DCs by MPM.23
LCs and dDCs are clearly visualized in CD11c-YFP mice (Fig. 2). In
the steady state skin, dDCs exhibit active motility with polarized
morphology.4,24,25 After hapten application, dDCs exhibit ammune cells by haptens
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Fig. 2. Representative MPM images of DCs and T cells in the skin. (a) LCs are visualized by green ﬂuorescence in langerin-eGFP mice. Melanocytes are also visualized by auto-
ﬂuorescence by melanin. (b) dDCs are visualized by green ﬂuorescence in CD11c-YFP mice crossed with DsRed mice. Skin structures, such as blood vessels and hair follicles, are
visualized by red ﬂuorescence (DsRed). (c) Effector OT-II GFP T cells are visualized by green ﬂuorescence. Collagen ﬁbers are visualized by the signals from second harmonic
generation (blue). (d) Lymphatic vessels are visualized by green ﬂuorescence in Prox1-GFP mice.
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almost twofold.4,25 Antigen-bearing DCs migrate from the skin to
the dLNs, but some dDCs form cluster structures in the skin around
18e24 h after hapten application.5 This leukocyte cluster is essen-
tial for effector T cell activation in the skin, as discussed in the next
section. The motility of dDCs in the skin appears to be regulated by
G protein-coupled receptor-mediated signaling, because the
administration of pertussis toxin signiﬁcantly impairs dDC motility
and probing behavior.25
Among the G-protein-coupled receptors, BLT1 receptor is one of
the candidates considered to regulate DC motility in the skin.4 BLT1
is a receptor of leukotriene B4 (LTB4), a lipid mediator derived from
arachidonic acid.26,27 Blockade of BLT1 signaling signiﬁcantly
down-regulates DC motility in both steady state skin and hapten-
treated inﬂammatory skin. Consequently, DC migration from the
skin to the dLNs and DC cluster formation in the skin are attenuated
by BLT1 signaling blockade, which leads to suppressed CHS re-
sponses.4 Stimulation of BLT1 signaling causes actin ﬁlament
reorganization in DCs through activation of Cdc42 and Rac1, and
increases DC motility.4 Intriguingly, BLT1 signaling increases DC
motility synergistically with chemokine (CeC motif) ligand 21 and
chemokine (C-X-C motif) ligand 2 (CXCL2), both of which play
essential roles in cutaneous DC migration.5,28 Thus, LTB4 may be an
important accelerator of chemokine-induced cutaneous DC
migration.In contrast to dDCs, LCs are basically immotile in the steady state
skin, although they constantly extend and retract dendrites, which
is called “dendrite surveillance extension and retraction cycling
habitude”.29 LCs have long been considered as the essential
antigen-presenting cells in CHS. However, recent studies using LCs-
deﬁcient mice have suggested the regulatory roles of LCs in the
sensitization phase of CHS via the production of IL-10 or the in-
duction of regulatory T cells.30e32 Hapten application increases LC
motility in the epidermis slightly, but the average velocity is much
lower than that of dDCs.25,33 Consistently, the kinetics of hapten-
induced migration from the skin to the dLNs is much slower in
LCs than in dDCs.34 The slow motility of LCs may generate the
regulatory characteristics of LCs.
DC cluster formation
As mentioned above, dDCs form clusters in the dermis after
hapten application. What is the formation mechanism and bio-
logical signiﬁcance of DC clusters? MPM analysis provides impor-
tant clues to answer these questions.5 Time-lapse imaging by MPM
revealed that DCs migrate toward perivascular macrophages on
post-capillary venules. IL-1a, CXCL2, and LTB4 are important mol-
ecules that create the clusters, and blockade of these molecules
thus signiﬁcantly impairs cluster formation.4,5 Keratinocytes are
supposed to be the major source of IL-1a. IL-1a activates
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of CXCL2. Inﬁltrated effector T cells then accumulate around the
clusters and are activated by antigen-bearing DCs in the cluster
(Fig. 3). The inhibition of the cluster formation signiﬁcantly atten-
uates effector T cell activation. These results indicate that DC clus-
ters serve as essential structures for efﬁcient T cell activation in the
skin. We propose that these structures should be termed “inducible
skin-associated lymphoid tissues (iSALT)” since they do not exist in
the steady state but are induced in inﬂammatory conditions.5,35
T cell dynamics and its regulation during the elicitation phase
Effector T cells inﬁltrate inﬂamed tissues with limited de-
pendency on their antigen speciﬁcity.3,36 Without their cognate
antigens, effector T cells exhibit active motility in the dermis.3,37
When effector T cells recognize their cognate antigens presented
by DCs, T cells initiate stable contact with DCs, and reduce their
motility.3,37 After the stable interaction with DCs, T cells produce
various cytokines and provoke inﬂammation.9 Here, to avoid
excessive tissue damages, the magnitude and quality of T cell ac-
tivity must be tightly regulated. The precise T cell dynamics and the
regulatorymechanisms involved in these processes remain unclear,
however, due to the lack of appropriate systems to control the
timing of initial antigen recognition by T cells in the skin.
Using a delayed-type hypersensitivity model in combination
with MPM analysis, we established a method that enables the
synchronization of effector T cell activation, and analyzed the reg-
ulatory mechanisms that control effector T cell dynamics and
effector function.3 After antigen recognition, effector T cells rapidly
cease motility and initiate stable interaction with DCs within
10 min. They gradually regain motility 1e2 h after antigen recog-
nition, and regain their original speed by 6e8 h. Intriguingly, the
cytokine production ability reaches a peak within 3 h after theHaptens
IL-1α
dDC
KCs
CXCL2
dDC M2 macrophag
Postcapillary veLTB4
Fig. 3. Schematic illustration of DC cluster formation mechanisms. (Left) Haptens indu
postcapillary venules. The stimulated macrophages then produce CXCL2, which attract dDCs.
Effector T cells are activated within the DC clusters (called iSALT) and produce cytokines, sinitial antigen contact, and then T cells cease making cytokine as
they regain motility, indicating an inverse correlation between
effector function and motility. Programmed death-1 (PD-1)
signaling negatively regulates the antigen sensitivity of effector T
cells and controls the duration of migration arrest and cytokine
production (Fig. 4).3 These negative feedback mechanisms are
responsible for the adequate T cell activation in inﬂammatory
skin.38
Similar PD-1-dependent regulatory mechanisms have been re-
ported in other peripheral tissues,39,40 although different mecha-
nisms may work depending on the tissue or experimental model.41
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), another
important negative regulator in the immune system, is also
involved in the control of antigen-induced T cell arrest and T cell
activation.42,43 Immune checkpoint molecules likely regulate T cell
activation in peripheral tissues in a spatiotemporal manner.
Dynamics of regulatory T cells in the skin
Regulatory T cell (Treg) is a subset of CD4þ T cells with strong
immunosuppressive activity.44 During the elicitation phase in CHS,
the number of skin Tregs signiﬁcantly increases, and the skin
homing Tregs posses stronger immunosuppressive activity than
LNs-resident Tregs.45,46 In addition, mice lacking skin Tregs spon-
taneously exhibit severe dermatitis,47 and loss of Tregs causes se-
vere dermatitis in humans.48 These observations indicate that skin
Tregs are essential for both the maintenance of skin homeostasis
and the termination of inﬂammatory responses.49
Chow et al. analyzed the dynamics of Tregs in skin by MPM, and
reported different patterns of migration ability between Tregs and
effector CD4þ T cells.50 In contrast to the uniformly high motility of
effector CD4þ T cells, most Tregs exhibited signiﬁcantly lower
motility in the steady state skin. In the inﬂammatory skin in theγ
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motility, most Tregs remained immotile. Although the biological
signiﬁcance of such different migration patterns remains unclear,
Tregs with lowmotility may be constantly interacting with DCs and
interfere with the stable DC-effector T cell interaction in the skin, as
observed in another model.51 In addition, Tregs with high motility
may be in the process of migration from the skin to the dLNs, since
skin Tregs constitutively migrate to the dLNs, and the number and
proportion of the migratory Tregs increase in the elicitation
phase.45 Elucidation of the factors that determine Tregmotility may
reveal the novel mechanisms by which Tregs exert their suppres-
sive function in the skin.The role of MCs and the dynamics in CHS
MCs are generally considered to be innate immune cells, but
there is now growing evidence that they play important functions
in both innate and adaptive immune responses. In CHS, the role of
MCs is controversial since conﬂicting results have been reported by
different groups. However, recent data using a novel MC-speciﬁc
depletion system indicate that MCs exert promoting roles and are
essential for the development of CHS.52e54 Furthermore, MPM
analysis using MC reporter mice revealed the unique functions of
MCs in CHS.55,56 MCs are located around blood vessels in thedermis, and are sessile in both the steady and inﬂammatory states.
Their elongated or spindle-like morphology in steady state skin
changes to a globular shape after an antigen challenge, however.56
An antigen challenge induces an increase in vascular permeability,
which is dependent on MC-derived histamines. This increased
permeability is essential for the initial neutrophil inﬁltration or
effector T cell inﬁltration in the elicitation phase.57 In the sensiti-
zation phase, MC-derived TNF-a induces cutaneous DC migration
and maturation, and promotes effector CD8þ T cell priming in
dLNs.52,54,56Concluding remarks
The development and progress of intravital imaging techniques
have signiﬁcantly extended our knowledge of cell dynamics in vivo,
including the morphological change, migration speed, and inter-
action time with other cells. Moreover, we have encountered un-
expected phenomena that have not previously been observed by
the conventional immunohistochemical method, and this has led to
the discovery of novel regulatory mechanisms and concepts related
to cutaneous immune system.MPM analysis is not just a tool for the
statistical analysis of previously reported biological phenomenon,
but is expected to be a great tool in the discovery of new biology.
T. Honda et al. / Allergology International 65 (2016) 228e234 233Currently, the application of MPM is mainly restricted in animal
studies, and the cell dynamics of human tissues remains unknown.
There already exists an MPMmachine that can be used on humans,
and the morphological analysis of epidermal cells in some skin
diseases has been performed.58e60 The development of novel cell-
labeling systems and further improvement in MPM will enable
the analysis of cell dynamics in humans in the future.
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